Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ADIL
ADIL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ADIL News
U.S. Stocks Decline in Morning Trading
Feb 05 2026
Benzinga
U.S. Stocks Mixed; Eli Lilly Shares Surge After Earnings Beat
Feb 04 2026
Benzinga
U.S. Stocks Mixed in Morning Trading
Feb 04 2026
Benzinga
Adial Pharmaceuticals Applauds New Legislation for Addiction Treatment
Feb 04 2026
Newsfilter
Super Micro Computer Q2 Earnings Exceed Expectations
Feb 04 2026
Benzinga
Adial Pharmaceuticals Announces 1-for-25 Reverse Stock Split
Feb 04 2026
stocktwits
Adial Pharmaceuticals to Execute 1-for-25 Reverse Stock Split
Feb 03 2026
seekingalpha
Adial Pharmaceuticals Enters Warrant Inducement Agreement, Raising $2.86 Million
Nov 26 2025
Globenewswire
Adial Pharmaceuticals Announces Financial Results for Q3 2025 and Offers Business Update
Nov 14 2025
Newsfilter
Adial Pharmaceuticals CEO Appeared as a Guest on The Big Biz Show
Oct 17 2025
Newsfilter
Adial Pharmaceuticals Collaborates with Genomind to Develop Precision Medicine Testing Solution
Oct 09 2025
Newsfilter
Semtech Analyst Becomes Optimistic; Check Out Tuesday's Top 5 Upgrades
Sep 30 2025
Benzinga
Adial Pharmaceuticals Showcases Positive Feedback from FDA Meeting Regarding Key Alcohol Use Disorder Program
Sep 16 2025
Benzinga
Everything You Should Know About Adial Pharmaceuticals (ADIL) Upgrade to Buy Rating
Sep 01 2025
NASDAQ.COM
Adial Pharmaceuticals Welcomes U.S. Senate Backing for Broader Clinical Trial Endpoints in Alcohol and Substance Use Disorder Treatments
Aug 20 2025
Newsfilter
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Aug 04 2025
Benzinga
Show More News
